Stevens Capital Management LP Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Stevens Capital Management LP reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 63.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,277 shares of the healthcare conglomerate's stock after selling 3,949 shares during the quarter. Stevens Capital Management LP's holdings in UnitedHealth Group were worth $1,152,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter worth $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $40,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

UNH stock traded down $2.92 during midday trading on Tuesday, hitting $513.58. The company's stock had a trading volume of 3,014,621 shares, compared to its average volume of 4,086,166. The stock has a market cap of $469.78 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's 50-day moving average price is $509.71 and its 200 day moving average price is $546.15.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.83 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.33% of the company's stock.

Analyst Ratings Changes

Several analysts recently weighed in on UNH shares. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Finally, Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.